Neogen Corp (STU:NG2)
€ 8.24 +0.060 (+0.73%) Market Cap: 2.19 Bil Enterprise Value: 2.72 Bil PE Ratio: 0 PB Ratio: 0.98 GF Score: 71/100

Q2 2025 Neogen Corp Earnings Call Transcript

Jan 10, 2025 / 01:00PM GMT
Release Date Price: €12.6

Key Points

Positve
  • Neogen Corp (NEOG) reported core revenue growth of 3.5% for the second quarter, driven by improvements in both food safety and animal safety segments.
  • The company saw significant progress in its food safety segment, with core revenue growth of nearly 4%, led by biosecurity products and bacterial sanitation products.
  • Neogen Corp (NEOG) is leveraging its broad product portfolio to address increasing regulatory focus on food safety, particularly in response to recent food contamination incidents.
  • The company is making strides in its restructuring efforts, particularly in its genomics business, to drive higher profitability and focus on large animal offerings.
  • Neogen Corp (NEOG) is on track to reach prior production levels for its relocated sample collection production by the end of the third quarter, which should help in recapturing market share.
Negative
  • Neogen Corp (NEOG) faced a decline in its global genomics revenue, driven by ongoing weakness in the companion animal side of the business.
  • The company experienced a negative impact from foreign exchange, which was a headwind of 250 basis points, affecting overall revenue growth.
  • Gross margin decreased by 190 basis points year-over-year, primarily due to higher shipping and distribution costs and elevated inventory impairments.
  • The ramp-up of sample collection production has taken longer than anticipated, impacting revenue as the company has been unable to fully meet demand.
  • Neogen Corp (NEOG) reported a significant non-cash goodwill impairment charge related to the acquisition of the former 3M Food Safety Division, affecting GAAP net income.
Operator

Good morning, ladies and gentlemen and welcome to the Neogen Corporation second quarter 2025 earnings conference call at this time. (Operator Instructions) This call is being recorded on Friday, January 10, 2025.

I would now like to turn the conference over to Bill Waelke. Please go ahead.

Bill Waelke
Neogen Corp - Investor Relations

Thank you for joining us this morning for the discussion of the second quarter of our 2025 fiscal year. I'll briefly cover the non-GAAP and forward-looking language before passing the call over to our CEO John Adent who will be followed by our CFO Dave Naemura.

Before the market opened today, we published our preliminary second quarter results as well as the presentation with both documents available in the investor relations section of our website. We are in the process of finalizing our quarterly financials, and while we do not expect them to actual results could differ from the preliminary results being discussed today on our call this morning. We will refer to certain non-GAAP financial measures that we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot